Former Chief Medical Officer · Aura Biosciences, Inc. (AURA)

Cadmus Rich

A named executive officer of Aura Biosciences in every fiscal year CompBrief holds from FY2020 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,669,182

Salary $388,125Stock awards $347,393

FY2022: $581,500

4th of 4 named executive officers at Aura Biosciences by FY2023 total.

4 named officers on file for Aura Biosciences, FY2023

Cadmus Rich’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Aura Biosciences’s whole pay program stands against its peers

  • Aura Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on AURA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2024 (DEF 14A).

Free

Get Cadmus Rich’s full pay file as a PDF — free

More than this page: up to 10 years of Cadmus’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Cadmus Rich compensation by year

Aura Biosciences Summary Compensation Table · all 4 fiscal years held
In US dollars, as Aura Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022FY2023
Salary$377,280$392,816$440,000$388,125
Bonus$124,488$0$0$0
Stock awards$0$367,500$0$347,393
Option awards$113,498$1,466,906$0$534,450
Non-equity incentive$0$154,002$123,200$0
Pension and deferred compensation$0$0$0$0
All other$17,100$17,400$18,300$399,214
Total$632,366$2,398,624$581,500$1,669,182

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Aura Biosciences, Inc. DEF 14A filed April 25, 2024, accession 0001193125-24-113878, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Aura Biosciences, Inc. filed document, accession 0001193125-24-113878. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2024.

$632K
$2.4M
$582K
$1.7M
FY20
FY21
FY22
FY23
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU34,125$302,348—
RSU13,124$116,279—
Option1,727—$4.25
Option52,500—$10.18
Option51,563—$14.00
Option47,076—$5.48

Per the Outstanding Equity Awards at Fiscal Year-End table in Aura Biosciences, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Aura Biosciences’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Elisabet de los PinosPresident, Chief Executive Officer and Director$4,044,598
J. Jill HopkinsChief Medical Officer and President of Research and Development$2,935,681
Julie FederChief Financial Officer$1,863,974
Cadmus Rich · this pageFormer Chief Medical Officer$1,669,182

The full Aura Biosciences compensation record

free company brief

This page is one person within Aura Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Aura Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Cadmus Rich's compensation dossier · One-time report. No refunds.